$31.10
0.722.37%
At close: -
$30.50
-0.60-1.93%
After Hours: 4:55 PM EDT
Veracyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Veracyte using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-24 | $0.36 | $0.26 | 38.5 % |
Q3 | 2024-11-06 | $0.33 | $0.17 | 94.1 % |
Q2 | 2024-08-06 | $0.30 | $-0.03 | 1100.0 % |
Q1 | 2024-05-07 | $-0.02 | $-0.17 | 88.2 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-24 | $118.63M | $116.69M | 1.66 % |
Q3 | 2024-11-06 | $115.86M | $109.87M | 5.45 % |
Q2 | 2024-08-06 | $114.43M | $99.99M | 14.4 % |
Q1 | 2024-05-07 | $96.84M | $93.37M | 3.72 % |
Veracyte (VCYT) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 24, 2025 for Q4.
The Actual EPS was $0.36, which beat the estimate of $0.26.
The Actual Revenue was $118.6M, which beat the estimate of $116.7M.
Browse earnings estimates, EPS, and revenue on all stocks.